Global registry launches to unlock secrets of rare wolfram syndrome
NCT ID NCT02841553
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is building a worldwide registry for people with Wolfram syndrome, a rare genetic disorder causing diabetes, vision loss, and hearing problems. Researchers will track how the disease progresses over time and analyze participants' genetic information. The goal is to better understand the condition and lay the groundwork for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide crucial insights into how Wolfram syndrome progresses, potentially guiding future treatments.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly improve health and may face challenges in collecting complete data from participants worldwide.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- FitBit coaching may help amputees walk more after surgery
- Can AI catch the leading cause of blindness before It's too late?
- Does feeling stigmatized worsen life quality for men with low testosterone?
- Can community hospitals in zambia master severe disease care?
- Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
- Brain training may sharpen aging minds in diabetes